The Use of Aromatherapy for Symptom Management

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02163369

Enrollment

Registered

2014-06-13

Start date

2014-07-31

Completion date

Unknown

Last updated

2015-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nausea, Vomiting and Anxiety Associated With Medical Oncology Patients

Brief summary

The purpose of this pilot study is to introduce the use of aromatherapy/essential oils to medical oncology patients at Central DuPage Hospital to assess their perceived effectiveness to relieve symptoms of nausea or vomiting and/or anxiety. Peppermint oil will be used for nausea/vomiting and lavender oil will be used for anxiety. This study will involve administration of aromatherapy to a convenience sample of patients, who will then be asked to complete a brief questionnaire. The questionnaire will involve a simple likert scale to measure efficacy (in the opinion of the patient) and simple multiple-choice questions to determine patients' likeliness to use aromatherapy again.

Interventions

DRUGPeppermint and Lavender Essential Oils

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

SUPPORTIVE_CARE

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Adult hospitalized medical oncology patients admitted to Central DuPage Hospital. * Age 18 years or greater. * Able to understand and speak English. * Women of non-childbearing potential or with childbearing potential with a negative pregnancy test documented during the hospital stay. * Able to understand concept of aromatherapy for treatment of distressing symptoms.

Exclusion criteria

* Prisoners. * Non-English speaking patients. * Under the age of 18. * Unable to comprehend the concept of aromatherapy. * Severe cognitive impairment. * Not experiencing the symptoms of nausea, vomiting or anxiety. * Women with child-bearing potential who have not had a negative pregnancy test during the hospital stay. * Patients with known allergy to lavender or peppermint.

Design outcomes

Primary

Measure	Time frame
Post Intervention Patient Interview Form	24hrs post aromatherapy

Countries

United States

Contacts

Primary ContactMary Lyons, MSN, APN/CNS, RN-BC, ONC

mary.lyons@cadencehealth.org630-933-6011

Backup ContactLorraine Mack, MSN, RN, CNL, OCN

lorraine.mack@cadencehealth.org630-933-3413

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026